Alex M. Azar II, the former president of the U.S. division of Eli Lilly, says the U.S. drug system encourages price increases — but he intends to work on that problem.

Emmarie Huetteman

Emmarie Huetteman, Correspondent, came to KHN from The New York Times, where she covered Congress with a focus on the House of Representatives and, most recently, the investigations into Russian meddling in the 2016 election. In 2015, she reported from the front lines of the nascent refugee crisis in Germany as part of the International Center for Journalists’ Arthur F. Burns Fellowship. A graduate of the University of Michigan, Emmarie also holds a master’s degree in public affairs reporting from Northwestern University’s Medill School, where she worked on an award-winning reporting project on the national security implications of climate change.